SAVOR ( Saxagliptin and Cardiovascular Outcomes in Patients with Type @ Diabetes Mellitus ) randomised @,@ patients with Type @ Diabetes Mellitus and a high-risk of cardiovascular events treated with current per oral antidiabetics and patients treated with saxagliptin or placebo .